| Costagliola, Ciro |
NCT06431113: Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in Glaucoma |
|
|
| Recruiting | 3 | 40 | Europe | Citicoline 500 mg plus Homotaurine 50 mg plus Pyrroloquinoline quinone (Neuprozin Mito® ) | IRCCS Policlinico S. Matteo, Federico II University, University of Roma La Sapienza | Glaucoma, Neuroprotection | 04/25 | 05/25 | | |
NCT06210373: Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye Syndrome |
|
|
| Recruiting | N/A | 124 | Europe | Myrialen Gel, Dexpanthenol 5%, Recugel | Fidia Farmaceutici s.p.a. | Dry Eye Disease | 11/24 | 12/24 | | |
NCT06664515: Changes InMPOD After Full-thickness Macular Hole Closure |
|
|
| Completed | N/A | 15 | Europe | Ciro Costagliola | Federico II University | Full Macular Hole | 07/23 | 10/24 | | |
NCT05969418: Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC |
|
|
| Completed | N/A | 50 | Europe | Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter | Federico II University | Macular Degeneration Choroidal Neovascularization | 07/23 | 12/23 | | |
| Vargas, Maria |
ODISSEA, NCT04860687: Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the Study. |
|
|
| Recruiting | N/A | 309 | Europe | | Azienda Sanitaria-Universitaria Integrata di Udine | Covid19, Post Traumatic Stress Disorder, Quality of Life | 11/21 | 12/21 | | |
| Completed | N/A | 24 | Europe | Immersion in virtual reality using Nordic Neurolab(™) Visual System | Ecole Polytechnique Fédérale de Lausanne, University Hospital, Geneva | Claustrophobia | 12/23 | 02/24 | | |
| Izzo, Raffaele |
| Recruiting | N/A | 10000 | Europe | | Federico II University | Hypertension; Heart Disease, Hypertensive | 03/17 | 04/30 | | |
| Completed | N/A | 10000 | Europe | | Federico II University | Acute Coronary Syndrome | 08/21 | 09/23 | | |
| Giugliano, Giuseppe |
| Recruiting | N/A | 1000 | Europe | Vascular ultrasound or other imaging methods according to current guidelines, Laboratory tests, Medical treatment according to current guidelines, Endovascular od surgical peripheral revascularizations | Federico II University | Peripheral Artery Disease | 05/31 | 05/31 | | |
| Servillo, Giuseppe |
NCT05403320: Cuff Pressure Control and Evacuation of Subglottic Secretions To Prevent Pneumonia |
|
|
| Completed | N/A | 270 | Europe, RoW | Continuous cuff pressure regulation, Intermittent cuff pressure regulation, Automatic subglottic secretion drainage, Manual subglottic secretion drainage, Tracheobronchial colonization assessment, Microaspiration assessment, VAP assessment | Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University of the Sacred Heart | Respiratory Failure | 01/24 | 04/24 | | |
| Trimarco, Bruno |
| Recruiting | N/A | 10000 | Europe | | Federico II University | Hypertension; Heart Disease, Hypertensive | 03/17 | 04/30 | | |
| Completed | N/A | 10000 | Europe | | Federico II University | Acute Coronary Syndrome | 08/21 | 09/23 | | |
| Miele, Erasmo |
| Recruiting | 3 | 120 | Europe, Canada, Japan, US, RoW | Vedolizumab IV, ENTYVIO, KYNTELES, MLN0002 | Takeda, Takeda Development Center Americas, Inc. | Crohn's Disease (CD) | 11/24 | 11/24 | | |
| Active, not recruiting | 3 | 121 | Europe, Canada, Japan, US, RoW | Vedolizumab, MLN0002, ENTYVIO, KYNTELES | Takeda, Takeda Development Center Americas, Inc. | Colitis, Ulcerative | 08/25 | 08/25 | | |
| Recruiting | 3 | 240 | Europe, Canada, Japan, US, RoW | Vedolizumab IV, MLN0002, ENTYVIO, KYNTELES, No Intervention | Takeda, Takeda Development Center Americas, Inc. | Ulcerative Colitis, Crohn's Disease | 08/31 | 08/31 | | |
| Staiano, Annamaria |
NCT04283864: Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease |
|
|
| Recruiting | N/A | 300 | Europe, RoW | | Weizmann Institute of Science, The Leona M. and Harry B. Helmsley Charitable Trust | Crohn Disease | 12/25 | 12/25 | | |
NCT05340712: Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation |
|
|
| Recruiting | N/A | 80 | Europe | new infant formula, Standard formula, Novalac 1 | United Pharmaceuticals, Delta Consultants | Functional Constipation | 12/23 | 09/24 | | |
NCT05904938: Oral Administration of Actitan-F in Paediatric Diarrhoea |
|
|
| Recruiting | N/A | 136 | Europe | Lenodiar Pediatric, Placebo | Aboca Spa Societa' Agricola, IQVIA RDS, IQVIA Solutions | Chronic Diarrhoea of Infants and/or Young Children | 12/24 | 12/24 | | |
| Cennamo, Gilda |
NCT05969418: Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC |
|
|
| Completed | N/A | 50 | Europe | Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter | Federico II University | Macular Degeneration Choroidal Neovascularization | 07/23 | 12/23 | | |
| Manca, Rosa |
NCT04283864: Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease |
|
|
| Recruiting | N/A | 300 | Europe, RoW | | Weizmann Institute of Science, The Leona M. and Harry B. Helmsley Charitable Trust | Crohn Disease | 12/25 | 12/25 | | |
